Evidence map›Paper›PMID 32357926›Full record

ArticleBMC cancer2020

Design of a randomized controlled trial of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors.

Soo Hyun Kim, Yu Hyeon Choe, Ah Reum Han, Gwui Jeong Yeon, Gyeong Hee Lee, Bo Gyeong Lee, Young Up Cho, Seho Park, Moon Hee Lee

Open access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Soo Hyun KimDepartment of Nursing, Inha University, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea. soohyun@inha.ac.kr.
Yu Hyeon ChoeDepartment of Nursing, Inha University, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea.
Ah Reum HanDepartment of Nursing, Inha University, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea.
Gwui Jeong YeonDepartment of Nursing, Inha University, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea.
Gyeong Hee LeeDepartment of Nursing, Inha University, 100 Inha-ro, Michuhol-gu, Incheon, 22212, South Korea.
Bo Gyeong LeeCollege of Nursing, The Research Institute of Nursing Science, Daegu Catholic University, Daegu, South Korea.
Young Up ChoDepartment of Surgery, Ilsan Women's & Children's Hospital, Cha University, Goyang, South Korea.
Seho ParkDivision of Breast Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea.
Moon Hee LeeDivision of Hematology-Oncology, College of Medicine, Inha University, Incheon, South Korea.
Inha University · KRCatholic University of Daegu · KRYonsei University · KR

Funding

Ministry of Education 2016R1D1A1B04932171
6 · The paper itself

Abstract

backgroundSelf-management is becoming essential for breast cancer survivors, but evidence about the effectiveness of self-management support (SMS) intervention is lacking. To address this issue, we developed a theory-based SMS intervention, the 'EMPOWER', aimed at empowering breast cancer survivors. Here we describe the rationale of the intervention and its development.

methodsThe conceptual framework of this study is the Chronic Care Model, which posits that SMS can influence patient-provider relationships and ultimately improve health outcomes. We will conduct a multi-center, 2-armed randomized controlled trial to assess the effectiveness of EMPOWER among post-treatment breast cancer survivors in South Korea. The trial will include 94 women who completed primary breast cancer treatment within the last 6 months. Participants will be randomly assigned to the intervention group or the wait-list control group (1:1). The intervention group will receive a 7-week partnership-based and needs-tailored SMS intervention via telephone counseling. The primary outcome is empowerment. The secondary outcomes include self-efficacy for post-treatment self-management behaviors, mental adjustment, psychological distress, and health-related quality of life (HRQOL). Data will be collected by self-reported questionnaire at baseline, post-intervention, and 3-month follow-up. DISCUSSION: We believe that the EMPOWER intervention could improve HRQOL of post-treatment breast cancer survivors by enhancing their empowerment. If found successful, it could aid clinicians engaged in the long-term care of breast cancer survivors.

trial registrationClinical Research Information Service, KCT0004794. Registered 5 March 2020.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsCancer SurvivorsFemaleFollow-Up StudiesHumansMiddle AgedMulticenter Studies as TopicNeeds AssessmentPrognosisQuality of LifeRandomized Controlled Trials as TopicResearch DesignSelf EfficacyBreast cancerEmpowermentHealth-related quality of lifeRandomized controlled trialSelf-efficacySelf-management

Identifiers

PMID32357926
PMCPMC7193410
OpenAlexW3023985028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.